https://stock.noler.com/us/stock/apexigen-inc https://stock.noler.com/us/stock/apexigen-inc/accounts-payable https://stock.noler.com/us/stock/apexigen-inc/accrued-liabilities-current https://stock.noler.com/us/stock/apexigen-inc/accumulated-depreciation https://stock.noler.com/us/stock/apexigen-inc/additional-paid-in-capital https://stock.noler.com/us/stock/apexigen-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/apexigen-inc/amortization-of-deferred-charges https://stock.noler.com/us/stock/apexigen-inc/amortization-of-financing-costs https://stock.noler.com/us/stock/apexigen-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/apexigen-inc/aoci https://stock.noler.com/us/stock/apexigen-inc/assets-held-in-trust https://stock.noler.com/us/stock/apexigen-inc/available-for-sale-debt-accumulated-gross-unrealized-gain-before-tax https://stock.noler.com/us/stock/apexigen-inc/available-for-sale-debt-accumulated-gross-unrealized-loss-before-tax https://stock.noler.com/us/stock/apexigen-inc/available-for-sale-debt-amortized-cost-basis https://stock.noler.com/us/stock/apexigen-inc/available-for-sale-debt-securities https://stock.noler.com/us/stock/apexigen-inc/basic-shares https://stock.noler.com/us/stock/apexigen-inc/business-acquisition-cost-of-acquired-entity-transaction-costs https://stock.noler.com/us/stock/apexigen-inc/capital-expenditures https://stock.noler.com/us/stock/apexigen-inc/cash https://stock.noler.com/us/stock/apexigen-inc/cash-acquired-from-acquisition https://stock.noler.com/us/stock/apexigen-inc/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/apexigen-inc/cash-and-equivalents https://stock.noler.com/us/stock/apexigen-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/apexigen-inc/cash-cash-equivalents-and-short-term-investments https://stock.noler.com/us/stock/apexigen-inc/cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/apexigen-inc/cash-flow-breakdown https://stock.noler.com/us/stock/apexigen-inc/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/apexigen-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/apexigen-inc/common-stock-shares-subscriptions https://stock.noler.com/us/stock/apexigen-inc/common-stock-value https://stock.noler.com/us/stock/apexigen-inc/comprehensive-income https://stock.noler.com/us/stock/apexigen-inc/concept-stock-issued-tag-2 https://stock.noler.com/us/stock/apexigen-inc/contract-liability https://stock.noler.com/us/stock/apexigen-inc/convertible-debt-fair-value-disclosures https://stock.noler.com/us/stock/apexigen-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/apexigen-inc/current-assets https://stock.noler.com/us/stock/apexigen-inc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/apexigen-inc/current-liabilities https://stock.noler.com/us/stock/apexigen-inc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/apexigen-inc/debt-convertible-conversion-price https://stock.noler.com/us/stock/apexigen-inc/debt-face-amount https://stock.noler.com/us/stock/apexigen-inc/deferred-costs https://stock.noler.com/us/stock/apexigen-inc/deferred-costs-current https://stock.noler.com/us/stock/apexigen-inc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/apexigen-inc/deferred-finance-costs-noncurrent-net https://stock.noler.com/us/stock/apexigen-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/apexigen-inc/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/apexigen-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/apexigen-inc/deferred-tax-assets-in-process-research-and-development https://stock.noler.com/us/stock/apexigen-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/apexigen-inc/deferred-tax-assets-net https://stock.noler.com/us/stock/apexigen-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/apexigen-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/apexigen-inc/deferred-tax-assets-tax-credit-carryforwards https://stock.noler.com/us/stock/apexigen-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-other https://stock.noler.com/us/stock/apexigen-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/apexigen-inc/defined-contribution-plan-employer-discretionary-contribution-amount https://stock.noler.com/us/stock/apexigen-inc/defined-contribution-plan-employer-matching-contribution-percent https://stock.noler.com/us/stock/apexigen-inc/depreciation https://stock.noler.com/us/stock/apexigen-inc/depreciation-and-amortization https://stock.noler.com/us/stock/apexigen-inc/diluted-shares https://stock.noler.com/us/stock/apexigen-inc/due-to-related-parties-current https://stock.noler.com/us/stock/apexigen-inc/due-to-related-parties-current-and-noncurrent https://stock.noler.com/us/stock/apexigen-inc/effective-tax-rate https://stock.noler.com/us/stock/apexigen-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/apexigen-inc/eps https://stock.noler.com/us/stock/apexigen-inc/eps-basic https://stock.noler.com/us/stock/apexigen-inc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/apexigen-inc/financing-cash-flow https://stock.noler.com/us/stock/apexigen-inc/form-d-other https://stock.noler.com/us/stock/apexigen-inc/gain-loss-on-derivative-instruments-net-pretax https://stock.noler.com/us/stock/apexigen-inc/gain-loss-on-investments https://stock.noler.com/us/stock/apexigen-inc/gain-loss-on-sale-of-investments https://stock.noler.com/us/stock/apexigen-inc/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/apexigen-inc/general-and-administrative-expense https://stock.noler.com/us/stock/apexigen-inc/impairment-of-long-lived-assets-held-for-use https://stock.noler.com/us/stock/apexigen-inc/income-tax https://stock.noler.com/us/stock/apexigen-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/apexigen-inc/increase-decrease-in-accrued-income-taxes-payable https://stock.noler.com/us/stock/apexigen-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/apexigen-inc/increase-decrease-in-contract-with-customer-liability https://stock.noler.com/us/stock/apexigen-inc/increase-decrease-in-derivative-liabilities https://stock.noler.com/us/stock/apexigen-inc/increase-decrease-in-operating-lease-liability https://stock.noler.com/us/stock/apexigen-inc/increase-decrease-in-other-noncurrent-assets https://stock.noler.com/us/stock/apexigen-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/apexigen-inc/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/apexigen-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/apexigen-inc/insider-transactions-stock-units https://stock.noler.com/us/stock/apexigen-inc/insider-transactions-stock-units/sales https://stock.noler.com/us/stock/apexigen-inc/insider-transactions-warrants https://stock.noler.com/us/stock/apexigen-inc/interest-expense-on-debt https://stock.noler.com/us/stock/apexigen-inc/investing-cash-flow https://stock.noler.com/us/stock/apexigen-inc/investment-income-interest https://stock.noler.com/us/stock/apexigen-inc/investment-income-net-amortization-of-discount-and-premium https://stock.noler.com/us/stock/apexigen-inc/lease-and-rental-expense https://stock.noler.com/us/stock/apexigen-inc/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/apexigen-inc/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/apexigen-inc/marketable-securities-unrealized-gain-loss https://stock.noler.com/us/stock/apexigen-inc/net-change-in-cash https://stock.noler.com/us/stock/apexigen-inc/net-income https://stock.noler.com/us/stock/apexigen-inc/notes-payable-related-parties-classified-current https://stock.noler.com/us/stock/apexigen-inc/number-of-operating-segments https://stock.noler.com/us/stock/apexigen-inc/oci-net-of-tax https://stock.noler.com/us/stock/apexigen-inc/operating-cash-flow https://stock.noler.com/us/stock/apexigen-inc/operating-expenses https://stock.noler.com/us/stock/apexigen-inc/operating-income https://stock.noler.com/us/stock/apexigen-inc/operating-lease-assets https://stock.noler.com/us/stock/apexigen-inc/operating-lease-expense https://stock.noler.com/us/stock/apexigen-inc/operating-lease-liability https://stock.noler.com/us/stock/apexigen-inc/operating-lease-liability-current https://stock.noler.com/us/stock/apexigen-inc/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/apexigen-inc/operating-lease-payments-due https://stock.noler.com/us/stock/apexigen-inc/operating-lease-payments-due-next-twelve-months https://stock.noler.com/us/stock/apexigen-inc/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/apexigen-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/apexigen-inc/other-expenses https://stock.noler.com/us/stock/apexigen-inc/other-noncash-income-expense https://stock.noler.com/us/stock/apexigen-inc/other-noncurrent-assets https://stock.noler.com/us/stock/apexigen-inc/other-nonoperating-income-expense https://stock.noler.com/us/stock/apexigen-inc/paid-in-capital-mark-to-market https://stock.noler.com/us/stock/apexigen-inc/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/apexigen-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/apexigen-inc/payments-of-financing-costs https://stock.noler.com/us/stock/apexigen-inc/payments-of-merger-related-costs-financing-activities https://stock.noler.com/us/stock/apexigen-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/apexigen-inc/payments-to-acquire-marketable-securities https://stock.noler.com/us/stock/apexigen-inc/payments-to-acquire-restricted-certificates-of-deposit https://stock.noler.com/us/stock/apexigen-inc/preferred-shares-facts https://stock.noler.com/us/stock/apexigen-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/apexigen-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/apexigen-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/apexigen-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/apexigen-inc/preferred-stock-value https://stock.noler.com/us/stock/apexigen-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/apexigen-inc/prepaid-expense-current https://stock.noler.com/us/stock/apexigen-inc/prepaid-insurance https://stock.noler.com/us/stock/apexigen-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/apexigen-inc/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/apexigen-inc/proceeds-from-issuance-of-private-placement https://stock.noler.com/us/stock/apexigen-inc/proceeds-from-sale-and-maturity-of-marketable-securities https://stock.noler.com/us/stock/apexigen-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/apexigen-inc/proceeds-from-sale-of-restricted-investments https://stock.noler.com/us/stock/apexigen-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/apexigen-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/apexigen-inc/proceeds-from-stock-plans https://stock.noler.com/us/stock/apexigen-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/apexigen-inc/property-plant-equipment https://stock.noler.com/us/stock/apexigen-inc/public-float https://stock.noler.com/us/stock/apexigen-inc/redeemable-noncontrolling-interest-equity-common-carrying-amount https://stock.noler.com/us/stock/apexigen-inc/related-party-transaction-selling-general-and-administrative-expenses-from-transactions-with-related-party https://stock.noler.com/us/stock/apexigen-inc/repayments-of-related-party-debt https://stock.noler.com/us/stock/apexigen-inc/research-and-development https://stock.noler.com/us/stock/apexigen-inc/restricted-stock-value-shares-issued-net-of-tax-withholdings https://stock.noler.com/us/stock/apexigen-inc/retained-earnings https://stock.noler.com/us/stock/apexigen-inc/sale-of-stock-consideration-received-on-transaction https://stock.noler.com/us/stock/apexigen-inc/severance-costs https://stock.noler.com/us/stock/apexigen-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-exercisable-options-average-exercise-price https://stock.noler.com/us/stock/apexigen-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-lower-range-limit https://stock.noler.com/us/stock/apexigen-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-number-of-exercisable-options https://stock.noler.com/us/stock/apexigen-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-number-of-outstanding-options https://stock.noler.com/us/stock/apexigen-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-outstanding-options-average-exercise-price-beginning-balance https://stock.noler.com/us/stock/apexigen-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-upper-range-limit https://stock.noler.com/us/stock/apexigen-inc/share-price https://stock.noler.com/us/stock/apexigen-inc/share-repurchases https://stock.noler.com/us/stock/apexigen-inc/shareholders-equity https://stock.noler.com/us/stock/apexigen-inc/shares-authorized https://stock.noler.com/us/stock/apexigen-inc/shares-issued https://stock.noler.com/us/stock/apexigen-inc/short-term-investments https://stock.noler.com/us/stock/apexigen-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/apexigen-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/apexigen-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/apexigen-inc/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/apexigen-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/apexigen-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/apexigen-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/apexigen-inc/stock-award-plan-modification-incremental-compensation-cost https://stock.noler.com/us/stock/apexigen-inc/stock-award-rsu-grants-in-period https://stock.noler.com/us/stock/apexigen-inc/stock-award-rsu-vested-in-period https://stock.noler.com/us/stock/apexigen-inc/stock-award-rsu-vested-in-period-total-fair-value https://stock.noler.com/us/stock/apexigen-inc/stock-based-compensation https://stock.noler.com/us/stock/apexigen-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/apexigen-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/apexigen-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/apexigen-inc/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/apexigen-inc/stock-issued-shares-issued-value-restricted-stock-award-gross https://stock.noler.com/us/stock/apexigen-inc/stock-issued-shares-issued-value-restricted-stock-award-net-of-forfeitures https://stock.noler.com/us/stock/apexigen-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/apexigen-inc/stock-issued-value-of-shares-issued-for-acquisitions https://stock.noler.com/us/stock/apexigen-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/apexigen-inc/stock-options-expirations-in-period https://stock.noler.com/us/stock/apexigen-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/apexigen-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/apexigen-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/apexigen-inc/stock-options-nonvested-grant-date-fair-value https://stock.noler.com/us/stock/apexigen-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/apexigen-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/apexigen-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/apexigen-inc/stock-options-vested-and-expected-to-vest-exercisable-aggregate-intrinsic-value https://stock.noler.com/us/stock/apexigen-inc/stock-options-vested-and-expected-to-vest-exercisable-average-exercise-price https://stock.noler.com/us/stock/apexigen-inc/stock-options-vested-and-expected-to-vest-exercisable-number https://stock.noler.com/us/stock/apexigen-inc/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/apexigen-inc/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/apexigen-inc/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/apexigen-inc/stock-options-vested-grant-date-fair-value https://stock.noler.com/us/stock/apexigen-inc/stock-options-vested-in-period-fair-value https://stock.noler.com/us/stock/apexigen-inc/stock-options-vested-number-of-shares https://stock.noler.com/us/stock/apexigen-inc/stock-redeemed-or-called-shares https://stock.noler.com/us/stock/apexigen-inc/stockholders-equity-other https://stock.noler.com/us/stock/apexigen-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/apexigen-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/apexigen-inc/tax-rate-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/apexigen-inc/tax-rate-reconciliation-nondeductible-expense-meals-and-entertainment https://stock.noler.com/us/stock/apexigen-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/apexigen-inc/tax-rate-reconciliation-tax-credits-other https://stock.noler.com/us/stock/apexigen-inc/taxes-other https://stock.noler.com/us/stock/apexigen-inc/taxes-payable-current https://stock.noler.com/us/stock/apexigen-inc/temporary-equity-accretion-to-redemption-value https://stock.noler.com/us/stock/apexigen-inc/temporary-equity-issue-period-increase-or-decrease https://stock.noler.com/us/stock/apexigen-inc/temporary-equity-par-or-stated-value-per-share https://stock.noler.com/us/stock/apexigen-inc/temporary-equity-redemption-price-per-share https://stock.noler.com/us/stock/apexigen-inc/temporary-equity-shares-outstanding https://stock.noler.com/us/stock/apexigen-inc/total-assets https://stock.noler.com/us/stock/apexigen-inc/total-liabilities https://stock.noler.com/us/stock/apexigen-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/apexigen-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/apexigen-inc/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/apexigen-inc/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/apexigen-inc/valuation-allowance-deferred-tax-asset-change-in-amount